Article
Introduction of mutations into the non-structural genes or 3' untranslated region of an attenuated dengue virus type 4 vaccine candidate further decreases replication in rhesus monkeys while retaining protective immunity.
Vaccine - 3 Sept 2004
Hanley Kathryn A, Manlucu Luella R, Manipon Gracielle G, Hanson Christopher T, Whitehead Stephen S, Murphy Brian R, Blaney Joseph E
Abstract excerpt
A dengue virus vaccine candidate, rDEN4Delta30, has been previously reported to be safe and immunogenic in humans, but a subset of vaccinees developed asymptomatic rash, elevation of liver enzymes and/or mild neutropenia. In the current study, mutations that had previously been shown to reduce replication of DEN4 virus in suckling mice and/or in SCID mice engrafted with human liver cells (SCID-HuH-7 mice) were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.